The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

Movement Disorders

Volumn 29, Issue 14, 2014, Pages 1758-1766

  Respondek, Gesine ^a,b,c   Stamelou, Maria ^c,d   Kurz, Carolin ^a,b   Ferguson, Leslie W ^e   Rajput, Alexander ^e   Chiu, Wan Zheng ^f   van Swieten, John C ^f   Troakes, Claire ^g   al Sarraj, Safa ^g   Gelpi, Ellen ^h   Gaig, Carles ^h   Tolosa, Eduardo ^h   Oertel, Wolfgang H ^c   Giese, Armin ⁱ   Roeber, Sigrun ⁱ   Arzberger, Thomas ⁱ   Wagenpfeil, Stefan ^a,j   Höglinger, Günter U ^a,b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF ATHENS   (Greece)

^e ROYAL UNIVERSITY HOSPITAL   (Canada)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j SAARLAND UNIVERSITY   (Germany)

more..

Author keywords

Clinical diagnostic criteria; Neuropathology; Phenotypes; Progressive supranuclear palsy

Indexed keywords

ADULT; AGED; AUTOPSY; BRAIN; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROGNOSIS; RETROSPECTIVE STUDY; SUPRANUCLEAR PALSY, PROGRESSIVE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RETROSPECTIVE STUDIES; SUPRANUCLEAR PALSY, PROGRESSIVE; TREATMENT OUTCOME;

EID: 84918581460     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26054     Document Type: Article

References (34)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
2. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128:1247-1258.
3. Dubas F, Gray F, Escourolle R. Steele-Richardson-Olszewski disease without ophthalmoplegia. 6 clinico-anatomic cases. [Review]. Rev Neurol (Paris) 1983;139:407-416.
4. Davis PH, Bergeron C, McLachlan DR. Atypical presentation of progressive supranuclear palsy. Ann Neurol 1985;17:337-343.
5. Campbell-Taylor I. Atypical presentation of progressive supranuclear palsy. Ann Neurol 1986;20:375.
6. Imai H, Narabayashi H, Sakata E. "Pure akinesia" and the later added supranuclear ophthalmoplegia. Adv Neurol 1987;45:207-212.
7. Kleinschmidt-DeMasters BK. Early progressive supranuclear palsy: pathology and clinical presentation. Clin Neuropathol 1989;8:79-84.
8. Matsuo H, Takashima H, Kishikawa M, et al. Pure akinesia: an atypical manifestation of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1991;54:397-400.
9. Imai H, Nakamura T, Kondo T, Narabayashi H. Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP? Adv Neurol 1993;60:622-625.
10. Mizusawa H, Mochizuki A, Ohkoshi N, Yoshizawa K, Kanazawa I, Imai H. Progressive supranuclear palsy presenting with pure akinesia. Adv Neurol 1993;60:618-621.
11. Daniel SE, de Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118:759-770.
12. Morris HR, Gibb G, Katzenschlager R, et al. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 2002;125:969-975.
13. Williams DR, Holton JL, Strand K, Revesz T, Lees AJ. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007;22:2235-2241.
14. Compta Y, Valldeoriola F, Tolosa E, Rey MJ, Martí MJ, Valls-Solé J. Long lasting pure freezing of gait preceding progressive supranuclear palsy: a clinicopathological study. Mov Disord 2007;22:1954-1958.
15. Tsuboi Y, Josephs KA, Boeve BF, et al. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 2005;20:982-988.
16. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006;66:41-48.
17. Ling H, de Silva R, Massey LA, et al. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol 2014;40:149-163.
18. Han HJ, Kim H, Park JH, et al. Behavioral changes as the earliest clinical manifestation of progressive supranuclear palsy. J Clin Neurol 2010;6:148-151.
19. Hassan A, Parisi JE, Josephs KA. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase 2012;18:478-488.
20. Donker Kaat L, Boon AJ, Kamphorst W, Ravid R, Duivenvoorden HJ, van Swieten JC. Frontal presentation in progressive supranuclear palsy. Neurology 2007;69:723-729.
21. Mochizuki A, Ueda Y, Komatsuzaki Y, Tsuchiya K, Arai T, Shoji S. Progressive supranuclear palsy presenting with primary progressive aphasia: clinicopathological report of an autopsy case. Acta Neuropathol 2003;105:610-614.
22. Boeve B, Dickson D, Duffy J, Bartleson J, Trenerry M, Petersen R. Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol 2003;49:72-78.
23. Josephs KA, Duffy JR. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol 2008;21:688-692.
24. Kanazawa M, Shimohata T, Toyoshima Y, et al. Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord 2009;24:1312-1318.
25. Iwasaki Y, Mori K, Ito M, Tatsumi S, Mimuro M, Yoshida M. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement. Neuropathology 2013;33:561-567.
26. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
27. Respondek G, Roeber S, Kretzschmar H, et al. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov Disord 2013;28:504-509.
28. Williams DR, Lee W. Clinical features and criteria for the diagnosis of progressive supranuclear palsy. Neurodegen Dis Manage 2012;2:1-9.
29. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS Neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). [Review]. Neurology 1994;44:2015-2019.
30. Birdi S, Rajput AH, Fenton M, et al. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord 2002;17:1255-1264.
31. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN, NNIPPS Study Group. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009;132:156-171.
32. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009;8:270-279.
33. Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;29;80:496-503.
34. Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004;19:181-189.